MATURATIONAL ROLES OF GNRH PULSE FREQUENCY
GNRH 脉冲频率的成熟作用
基本信息
- 批准号:3313375
- 负责人:
- 金额:$ 14.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-03-01 至 1996-02-28
- 项目状态:已结题
- 来源:
- 关键词:adolescence (12-20) adult human (21+) amenorrhea blood chemistry child (0-11) circadian rhythms dexamethasone estradiol estrogens female gonadotropin releasing factor hormone regulation /control mechanism human puberty human subject hypogonadism injection /infusion luteinizing hormone male menstrual cycle naloxone neuroendocrine system neuropeptides opioid receptor ovary ovulation polycystic ovary syndrome progesterone radioimmunoassay reproductive development sex hormones testosterone urinalysis
项目摘要
The overall goal of this project is to examine the regulation and roles of
pulsatile GnRH secretion in human beings: a) throughout sexual maturation,
and b) in the maintenance of normal cyclical ovulation. All of the
proposed studies are directed toward the unifying hypothesis that the
ability to secrete GnRH at a "fast" approximately circhoral, or "faster"
frequency throughout the day develops during puberty, and that the ability
to change the frequency and amplitude of pulsatile GnRH secretion is
critical for cyclical ovarian follicular maturation and ovulation. This
hypothesis will be approached in several ways. Specifically we plan 1)
detailed evaluation of the sleep-entrained patterns of GnRH and sex steroid
(T and E2) secretion in normal and hypogonadal children; 2) examination of
the acute effects of sex steroids, either via stimulation by pulsatile
GnRH, intravenous infusion, or transcutaneous absorption, on the sleep-
entrained patterns of GnRH secretion in pubertal boys and men; 3)
examination of the role of endogenous opioids, via opioid receptor blockade
in the sex steroid regulation of GnRH secretion in pubertal boys and normal
men; 4) examination of the role of E2 in regulating GnRH pulse frequency
throughout the transition from luteal to follicular stages of the menstrual
cycle; 5) examination of the hypothesis that polycystic ovarian disease
(PCO) results from fast frequency GnRH secretion, and evaluation of the
effects of E2 and P in slowing GnRH secretion and inducing ovulation; and
6) examination of the role of excess hypothalamic opioid activity in the
slow frequency GnRH secretion in hypothalamic amenorrhea, and evaluation of
naltrexone in inducing ovulation. The principal approaches to these
objectives will include: a) indirect assessment of GnRH secretion via
detailed assessment of the secretory patterns of immunoreactive LH; b)
assessment of the acute effects of sex steroid infusion on the sleep-
entrained increase in gonadotropin secretion in pubertal boys; c) opioid
receptor blockade via nalaxone or naltrexone to investigate the role(s) of
endogenous opioids in gonadotropin regulation; d) administration of
physiological amounts of E2 and P to normal women and women with PCO to
test the hypothesis that PCO syndrome is the result of excess hypothalamic
pulsatile secretion of GnRH, and e) evaluation of the effects of
dexamethasone on LH secretion in patients who have hypothalamic amenorrhea
but who are unresponsive to opioid blockade. Normal adult men and women,
and adults and children with suspected or proven hypothalamic/pituitary
dysfunction will participate in detailed protocols performed in the
Clinical Research Center. Well established radioimmunoassays will be used
for serial hormone determinations, and objective computer analyses will be
used for determination of pulsatile secretory patterns. These studies
should provide a more thorough understanding of the physiology of human
reproduction and should lead to more rational therapies for patients with
precocious or delayed maturation. Moreover, the possibilities that
anovulation can also result from fast frequency GnRH secretion (or an
inability to slow GnRH secretion) will be examined and the results may lead
to novel, physiological approaches to ovulation induction in these
patients.
这个项目的总体目标是检查的规则和角色
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT P KELCH其他文献
ROBERT P KELCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT P KELCH', 18)}}的其他基金
RES FACIL CONST: PROTEIN STRUCTURE, ARTIFICIAL ENDONUCLEASE, DRUG DESIGN
RES FACIL CONST:蛋白质结构、人工核酸内切酶、药物设计
- 批准号:
6794504 - 财政年份:2002
- 资助金额:
$ 14.36万 - 项目类别:
ADVANCING CHILD HEALTH THROUGH CELL/MOLECULAR BIOLOGY
通过细胞/分子生物学促进儿童健康
- 批准号:
3103147 - 财政年份:1991
- 资助金额:
$ 14.36万 - 项目类别:
ADVANCING CHILD HEALTH THROUGH CELL/MOLECULAR BIOLOGY
通过细胞/分子生物学促进儿童健康
- 批准号:
3103148 - 财政年份:1991
- 资助金额:
$ 14.36万 - 项目类别:
ADVANCING CHILD HEALTH THROUGH CELL/MOLECULAR BIOLOGY
通过细胞/分子生物学促进儿童健康
- 批准号:
3103146 - 财政年份:1991
- 资助金额:
$ 14.36万 - 项目类别:














{{item.name}}会员




